1,609
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Functional characterization of all missense variants in LEPR, PCSK1, and POMC genes arising from single-nucleotide variants

, , , &
Pages 209-219 | Received 23 Dec 2022, Accepted 09 Feb 2023, Published online: 02 Mar 2023

References

  • Yazdi FT, Clee SM, Meyre D. Obesity genetics in mouse and human: back and forth, and back again. PeerJ. 2015;3:e856.
  • Farooqi IS. Monogenic obesity syndromes provide insights into the hypothalamic regulation of appetite and associated behaviors. Biol Psychiatry. 2022;91(10):856–859.
  • Krashes MJ, Lowell BB, Garfield AS. Melanocortin-4 receptor-regulated energy homeostasis. Nat Neurosci. 2016;19(2):206–219.
  • Sket R, Kotnik P, Bizjan BJ, et al. Heterozygous genetic variants in autosomal recessive genes of the leptin-melanocortin signalling pathway are associated with the development of childhood obesity. Front Endocrinol (Lausanne). 2022;13:832911.
  • Bend EA, Antao T, Ichetovkin I, et al. Frequency of MC4R pathway variants in a large US cohort of pediatric and adult patients with severe obesity. Poster session presented at: European Society for Peadiatric Endocrinology; 2021 Sept 22 –26;Virtual.
  • Challis BG, Pritchard LE, Creemers JW, et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet. 2002;11(17):1997–2004.
  • Creemers JW, Choquet H, Stijnen P, et al. Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes. 2012;61(2):383–390.
  • da Fonseca ACP, Mastronardi C, Johar A, et al. Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies. J Diabetes Complications. 2017;31(10):1549–1561.
  • Dubern B, Lubrano-Berthelier C, Mencarelli M, et al. Mutational analysis of the pro-opiomelanocortin gene in French obese children led to the identification of a novel deleterious heterozygous mutation located in the alpha-melanocyte stimulating hormone domain. Pediatr Res. 2008;63(2):211–216.
  • Farooqi IS, Volders K, Stanhope R, et al. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. J Clin Endocrinol Metab. 2007;92(9):3369–3373.
  • Farooqi IS, Wangensteen T, Collins S, et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med. 2007;356(3):237–247.
  • Moeller IHK, Kleyn P, Sleiman PM, et al. Frequency of MC4R pathway variants in a large US cohort of patients with severe obesity. Poster session presented at: Obesity Week; 2021 Nov 1 –5;Virtual.
  • Crouse JA, Elliott GE, Burgess TL, et al. Altered cell surface expression and signaling of leptin receptors containing the fatty mutation. J Biol Chem. 1998;273(29):18365–18373.
  • Lee YS, Challis BG, Thompson DA, et al. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006;3(2):135–140.
  • Martin MG, Lindberg I, Solorzano-Vargas RS, et al. Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort. Gastroenterology. 2013;145(1):138–148.
  • Stratigopoulos G, LeDuc CA, Matsuoka N, et al. Functional consequences of the human leptin receptor (LEPR) Q223R transversion. Obesity (Silver Spring). 2009;17(1):126–135.
  • Wilschanski M, Abbasi M, Blanco E, et al. A novel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activity. PLoS One. 2014;9(10):e108878.
  • Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424.
  • Seyerle AA, Avery CL. Genetic epidemiology: the potential benefits and challenges of using genetic information to improve human health. N C Med J. 2013;74(6):505–508.
  • Simcikova D, Heneberg P. Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases. Sci Rep. 2019;9(1):18577.
  • Gasperini M, Starita L, Shendure J. The power of multiplexed functional analysis of genetic variants. Nat Protoc. 2016;11(10):1782–1787.
  • Gelman H, Dines JN, Berg J, et al. Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation. Genome Med. 2019;11(1):85.
  • Harrison SM, Rehm HL. Is ‘likely pathogenic’ really 90% likely? Reclassification data in ClinVar. Genome Med. 2019;11(1):72.
  • Lotta LA, Mokrosinski J. Mendes de Oliveira E, et al. Human gain-of-function MC4R Variants Show Signaling Bias and Protect against Obesity. Cell. 2019;177(3):597–607 e599.
  • Uncovering rare obesity®. Rhythm Pharmaceuticals, Inc; 2022 [cited 2022 Nov] Available from: https://uncoveringrareobesity.com/
  • Kleyn P, Bromberg E, Norton R. Variants in obesity-related genes in a population with early-onset obesity. Poster session presented at: Obesity Week; 2022 Nov 1–4; San Diego (CA).
  • Baumann H, Morella KK, White DW, et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci U S A. 1996;93(16):8374–8378.
  • Blanco EH, Ramos-Molina B, Revisiting LI. PC1/3 mutants: dominant-negative effect of endoplasmic reticulum-retained mutants. Endocrinology. 2015;156(10):3625–3637.
  • Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–443.
  • Cunningham F, Allen JE, Allen J, et al. Ensembl 2022. Nucleic Acids Res. 2022;50(D1):D988–D995.
  • Landrum MJ, Chitipiralla S, Brown GR, et al. ClinVar: improvements to accessing data. Nucleic Acids Res. 2020;48(D1):D835–D844.
  • Couturier C, Jockers R. Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers. J Biol Chem. 2003;278(29):26604–26611.
  • Voigtmann F, Wolf P, Landgraf K, et al. Identification of a novel leptin receptor (LEPR) variant and proof of functional relevance directing treatment decisions in patients with morbid obesity. Metabolism. 2021;116:154438.
  • Mbikay M, Sirois F, Nkongolo KK, et al. Effects of rs6234/rs6235 and rs6232/rs6234/rs6235 PCSK1 single-nucleotide polymorphism clusters on proprotein convertase 1/3 biosynthesis and activity. Mol Genet Metab. 2011;104(4):682–687.
  • Williamson DM, Elferich J, Shinde U. Mechanism of fine-tuning pH sensors in proprotein convertases: identification of a pH-sensing histidine pair in the propeptide of proprotein convertase 1/3. J Biol Chem. 2015;290(38):23214–23225.
  • Cantara S, Chiofalo F, Ciuoli C, et al. Rare POMC mutation in a patient with myotonic dystrophy type 1 and adrenocorticotropin hyperresponse to corticotropin-releasing hormone. AACE Clin Case Rep. 2019;5(2):e132–e137.
  • Loffler D, Behrendt S, Creemers JWM, et al. Functional and clinical relevance of novel and known PCSK1 variants for childhood obesity and glucose metabolism. Mol Metab. 2017;6(3):295–305.
  • Koks S, Nikopensius T, Koido K, et al. Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol. 2006;9(2):167–174.
  • Silvia C, Francesco C, Cristina C, et al. A rare mutation of POMC gene in a patient with myotonic dystrophy type 1 and adrenocorticotropin hyperresponse to corticotrophin-releasing hormone. AACE Clin Case Rep. 2018;5(2):e132–e137.